UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
OACCW holding history
Oaktree Acquisition Corp. III Life Sciences in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OACCW overviewAll 13F holders of OACCWFull Q2 2026 holdings
- Shares (Q2 2026)
- 561
- Value
- $528
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 561 | $528 | <0.1% | +299+114.1% | Added | Holders |
| Q1 2026 | 262 | $138 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 262 | $183 | <0.1% | −1,046−80.0% | Reduced | Holders |
| Q3 2025 | 1,308 | $981 | <0.1% | −24,144−94.9% | Reduced | Holders |
| Q2 2025 | 25,452 | $22.3K | <0.1% | −5,578−18.0% | Reduced | Holders |
| Q1 2025 | 31,030 | $23.3K | <0.1% | +31,030 | New | Holders |